On Friday, Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $13.3 which represents a slight increase of $1.15 or 9.47% from the prior close of $12.15. The stock opened at $12.32 and ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Novavax uses a protein-based vaccine strategy, which means people getting the vaccine receive a protein made by the virus ...

The Ministry of Food and Drug Safety approved Novavax's vaccine for emergency use today (30th) in response to the "COVID-19 ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...

Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

It’s fall, which means it’s time to get updated on the winter season shots. That includes vaccines for flu, RSV (for babies and the elderly) and, for anyone six months or older, COVID-19.

Novavax Inc. closed $10.57 below its 52-week high ($23.86), which the company reached on June 6th.

Health Canada said Thursday it has authorized Novavax's updated COVID-19 vaccine for those aged 12 years and up.